{
    "2018-12-19": [
        [
            {
                "time": "2018-01-01",
                "original_text": "加码20亿元！药明康德再次对上海药明进行增资",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上海药明",
                        "增资",
                        "20亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "大手笔20亿 药明康德今年再次增资上海药明",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上海药明",
                        "增资",
                        "20亿"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "药明康德出资20亿元对上海药明进行增资",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上海药明",
                        "增资",
                        "20亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "药明康德拟以20亿元现金增资子公司上海药明",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上海药明",
                        "增资",
                        "20亿元",
                        "子公司"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "药明康德：拟以20亿元现金增资全资子公司上海药明",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上海药明",
                        "增资",
                        "20亿元",
                        "全资子公司"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "2018年A股IPO：11省颗粒无收 中金成最大赢家",
                "features": {
                    "keywords": [
                        "A股IPO",
                        "中金",
                        "颗粒无收",
                        "11省"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}